EpiVario
EpiVario reported $185,000 raised in an SEC Form D filed on 2026-10-13. State of the filing: Pennsylvania.
- Industry
- Pharmaceuticals
- Location
- Pennsylvania
About
EpiVario appears in Section 3 of the Raise Track Update of 2026-10-14, which lists new SEC Form D filings. The filing reports $185,000 raised and gives Pennsylvania as the state. The industry on the filing is Pharmaceuticals. Related persons named on the filing: Thomas Kim (executive officer, director, Philadelphia, Pennsylvania); Christopher Cashman (director, Philadelphia, Pennsylvania); Eric Schultenover (director, Philadelphia, Pennsylvania). Filing: https://www.sec.gov/Archives/edgar/data/1753351/000175335126000001/0001753351-26-000001-index.htm
This page is not indexed by search engines yet. A Form D on its own does not name investors or a round type, so the page is promoted once a second source confirms the raise.
Funding history
| Round | Date | Amount | Lead |
|---|---|---|---|
| Form D 2026 | 2026-10-13 | $185K |
Sources
Last verified:
- https://www.sec.gov/Archives/edgar/data/1753351/000175335126000001/0001753351-26-000001-index.htm
Type: sec filing. Accessed 2026-10-14.
SEC Form D for EpiVario Inc. EDGAR filing date 2026-10-13. Signed 2026-10-13. First sale 2026-09-25. Total amount sold $185,000 of an offering amount of $500,000. 9 investors already invested. Issuer address city is Philadelphia, Pennsylvania. Jurisdiction of incorporation is Delaware. The form does not name those investors or a round type. Street addresses are not published. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-14/
Type: other verified public source. Accessed 2026-10-14.
Raise Track Update for 2026-10-14, Section 3 (SEC Form D filings). Lists EpiVario, state PENNSYLVANIA, industry Pharmaceuticals, amount raised $185,000.